Market Overview Global atopic dermatitis clinical trials market size was valued at USD 2.34 billion in 2023. The market is anticipated to grow from USD 2.59 billion in 2024 to USD 6.11 billion by 2032, exhibiting a CAGR of 11.3% during the forecast period In terms of segmentation, large‑molecule (biologic) therapies held a dominant share (approximately 54% in 2024) of the AD clinical trials...